SELL Cipla Ltd. — Jefferies India
byJefferies IndiaHorizon: NA (inferred 1 year)24 Jul 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·7 Sept · today
Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field
NewsHbl·4 Sept · 3d ago
Cipla Pharma license cancellation: FDA withdraws order after Bombay HC raps it for going 'overboard'
NewsCnbc-Tv18·29 Aug · 1w ago
FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads
NewsNdtv-Profit·28 Aug · 1w ago
Cipla gets seven USFDA observations for Pithampur plant after follow-up inspection
NewsCnbc-Tv18·25 Aug · 2w ago
Cipla Ltd is intimating shareholders and creditors about a notice regarding a Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited with Cipla Limited. The notice provides an opport
BSE · Company Update·3 Sept · 4d ago
US FDA classifies Cipla subsidiary’s New York facility inspection as ‘Voluntary Action Indicated’
NewsCnbc-Tv18·29 Aug · 1w ago
Cipla Pharma License Cancellation: FDA Withdraws Order After HC Raps It For Going "Overboard"
NewsNdtv-Profit·29 Aug · 1w ago
Cipla shares slip after USFDA observations; Citi says no earnings impact, target at ₹1,700
NewsCnbc-Tv18·26 Aug · 2w ago
Nifty, Sensex open lower; TCS, Eternal gain, Cipla, Maruti slip
NewsHbl·25 Aug · 2w ago
Explained: Why Morgan Stanley has the second-lowest price target on the Street for this drugmaker
NewsCnbc-Tv18·4 Sept · 3d ago
Cipla announces exclusive US partnership with Qilu Pharma for keytruda biosimilar
NewsCnbc-Tv18·3 Sept · 3d ago
Cipla announces an exclusive partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to Keytruda (Pembrolizumab) in the US.
BSE · Company Update·3 Sept · 4d ago
Sun Pharma, Cipla have more upside; Chinese drug deals may lower oncology costs: Systematix
NewsCnbc-Tv18·1 Sept · 6d ago
Cipla shares gain after it inks cancer treatment drug licensing deal with Sino Biopharma arm
NewsCnbc-Tv18·1 Sept · 6d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.